Solventum Corporation
Financials
Valuation Metrics
Solventum Corporation's Market Cap is $14.67B. At end of 2025 it was $13.80B. Ranked #732 of 3,118 in US market (top 23%), #505 of 1,644 on NYSE (top 31%), #48 of 203 in Health Care Equipment & Services (top 24%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $14.67B | US#732/3,118 Sec#48/203 |
| Revenue | $8.31B | US#634/3,118 Sec#37/203 |
| Net Income | $1.43B | US#421/3,118 Sec#22/203 |
| Total Assets | $14.24B | US#786/3,118 Sec#36/203 |
| Net Assets | $4.80B | US#715/3,118 Sec#40/203 |
| Employees | 20,584 | US#538/3,118 Sec#37/203 |
| Value | ||
| P/E | 10.23x | US#329/3,118 Sec#5/203 |
| P/B | 3.06x | US#1,754/3,118 Sec#90/203 |
| PEG | 0.04x | US#97/3,118 Sec#4/203 |
| P/S | 1.77x | US#1,142/3,118 Sec#78/203 |
| EV/EBITDA | 7.53x | US#434/3,118 Sec#12/203 |
| FCF Yield | -0.80% | US—/3,118 Sec—/203 |
| Profitability | ||
| ROE | 29.88% | US#299/3,118 Sec#13/203 |
| ROA | 10.07% | US#483/3,118 Sec#29/203 |
| Op. Margin | 24.99% | US#672/3,118 Sec#17/203 |
| Revenue Growth | -0.93% | US#2,256/3,118 Sec#171/203 |
| Earnings Growth | 277.37% | US#126/3,118 Sec#6/203 |
| Financial Health | ||
| Debt Ratio | 196.73% | US#1,768/3,118 Sec#151/203 |
| Total Debt | $5.29B | US#644/3,118 Sec#31/203 |
| FCF | $-118M | US#2,663/3,118 Sec#191/203 |
| Cash | $403M | US#1,206/3,118 Sec#71/203 |
| Current Ratio | 1.02x | US#2,245/3,118 Sec#189/203 |
| Net Debt/EBITDA | 1.88x | US#1,295/3,118 Sec#79/203 |
| Performance | ||
| 1Y Return | 22.73% | US#1,240/3,118 Sec#102/203 |
| 1M Return | -3.55% | US#2,337/3,118 Sec#168/203 |
| From 52W High | -10.01% | US#1,080/3,118 Sec#87/203 |
| 1Y MDD | -27.46% | US#1,116/3,118 Sec#46/203 |
| Trading | ||
| Volume | 655,729 shares | US#1,714/3,118 Sec#122/203 |
| Trading Value | $55M | US#1,141/3,118 Sec#84/203 |
| Per Share | ||
| EPS | $8.28 | US#382/3,118 Sec#26/203 |
| BPS | $27.72 | US#955/3,118 Sec#57/203 |
Company Info
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.